QYLD vs XLV
Global X Nasdaq 100 Covered Call ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.60% for QYLD.
- • QYLD pays a higher dividend yield (5.97%).
Side-by-side metrics
| Metric | QYLD | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.60% | 0.08% |
Dividend yield Trailing 12-month yield. | 5.97% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $8.20B | $49.10B |
YTD return | 10.56% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.47 | 0.41 |
P/E ratio | 28.74 | 30.63 |
Last price | $18.06 | $187.94 |
Inception | — | — |
Issuer | Global X | State Street |
QYLD top holdings
| AAPL | Apple Inc | 8.24% |
| NVDA | NVIDIA Corp | 8.08% |
| MSFT | Microsoft Corp | 6.35% |
| MU | Micron Technology Inc | 4.52% |
| AMZN | Amazon.com Inc | 4.25% |
| AMD | Advanced Micro Devices Inc | 3.73% |
| TSLA | Tesla Inc | 3.44% |
| META | Meta Platforms Inc Class A | 3.00% |
| WMT | Walmart Inc | 2.72% |
| GOOGL | Alphabet Inc Class A | 2.69% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About QYLD
QYLD (Global X Nasdaq 100 Covered Call ETF) is Nasdaq-100 covered call income strategy. Managed by Global X, the fund carries $8.2B in assets under management, an expense ratio of 0.60%, a dividend yield of 5.97%. Its largest holding is Apple Inc (AAPL), which represents 8.2% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 11.0%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.